Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2009-5-8
pubmed:abstractText
No treatment has consistently induced long-term remission of proteinuria in adult patients with focal segmental glomerulosclerosis (FSGS) recurrence after kidney transplantation. We undertook an open-label, nonrandomized pilot trial of intensive and prolonged treatment of FSGS recurrence. Over an 18-month period, 10 adult kidney transplant recipients with FSGS recurrence received concomitantly high-dose steroids, intravenous cyclosporine for 14 days followed by oral cyclosporine therapy, and an intensive and prolonged course of plasma exchanges (PE). We compared this treatment with those of a control group of 19 patients with a FSGS recurrence transplanted between 1997 and 2005. Complete, rapid (mean 23 +/- 7 days) and sustained remission was obtained in 9/10 patients (90%) as opposed to 27% in the control group. At month 3 and month 12, proteinuria was 0.16 g/day (range 0.05-0.3 g/day) and 0.19 g/day (range 0.05-1 g/day) respectively. Only one patient remained in partial remission at month 12 but he had already lost two previous grafts due to FSGS recurrence. PEs were stopped at month 9 in all patients except for the patient with a partial remission who remains PE-dependent. This small pilot study provides very encouraging results demonstrating that this treatment rapidly achieves complete and sustained remission in a high proportion of patients.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1600-6143
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
9
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1081-6
pubmed:meshHeading
pubmed-meshheading:19344432-Adolescent, pubmed-meshheading:19344432-Adult, pubmed-meshheading:19344432-Age of Onset, pubmed-meshheading:19344432-Child, pubmed-meshheading:19344432-Child, Preschool, pubmed-meshheading:19344432-Continental Population Groups, pubmed-meshheading:19344432-Disease Progression, pubmed-meshheading:19344432-Drug Therapy, Combination, pubmed-meshheading:19344432-Female, pubmed-meshheading:19344432-Glomerulosclerosis, Focal Segmental, pubmed-meshheading:19344432-Humans, pubmed-meshheading:19344432-Immunosuppressive Agents, pubmed-meshheading:19344432-Kidney Failure, Chronic, pubmed-meshheading:19344432-Kidney Transplantation, pubmed-meshheading:19344432-Male, pubmed-meshheading:19344432-Pilot Projects, pubmed-meshheading:19344432-Proteinuria, pubmed-meshheading:19344432-Recurrence, pubmed-meshheading:19344432-Remission Induction, pubmed-meshheading:19344432-Retrospective Studies, pubmed-meshheading:19344432-Tissue Donors, pubmed-meshheading:19344432-Young Adult
pubmed:year
2009
pubmed:articleTitle
Intensive and prolonged treatment of focal and segmental glomerulosclerosis recurrence in adult kidney transplant recipients: a pilot study.
pubmed:affiliation
Université Paris Descartes, 7 Rue de l'Ecole de Médecine, Paris 75007, France. guillaume.canaud@nck.aphp.fr
pubmed:publicationType
Journal Article